Table 2. Intermediate health outcomes of HPV vaccinationa,b.
| Outcome | HPV vaccination | No vaccination | Lifetime cases averted | No. needed to vaccinate to prevent one case |
|---|---|---|---|---|
| HPV |
1,460,699 |
1,684,954 |
224,255 |
9 |
| SIL |
417,549 |
530,259 |
112,710 |
18 |
| Cervical cancer |
13,374 |
16,690 |
3,316 |
600 |
| Cervical-cancer deaths | 5,121 | 6,461 | 1,340 | 1,484 |
aAssumes program that successfully administers a vaccine against high-risk HPV to the current U.S. cohort of 12-year-old girls.
bHPV, Human papillomavirus; SIL, squamous intraepithelial lesions.